Diabetes: limited access to Ozempic, a loss of opportunity for patients? – In the news
2023-12-11 16:25:56 December 11, 2023 The ANSM now recommends the prescription of Victoza, Ozempic and Trulicity, GLP-1 analogues used in the treatment of diabetes, only to patients already under treatment. “A loss of opportunity for patients at high cardiovascular risk,” regrets Jean-François Thébaut, cardiologist, vice-president of the French diabetics federation. Last week, the Novo Nordisk … Read more